SEC Filings

8-K
PERNIX THERAPEUTICS HOLDINGS, INC. filed this Form 8-K on 02/27/2019
Entire Document
 

Table of Contents
(continued)

 

Page

 

6.8   Accounting Methods 37
6.9   Investments 37
6.10   Transactions with Affiliates 37
6.11   Use of Proceeds 38
6.12   Limitation on Issuance of Equity Interests 38
6.13   Negative Pledge 38
6.14   Borrower and IP Subsidiaries 38
6.15   Burdensome Agreements 39
6.16   Agent’s Exercise of Rights and Remedies. 40
6.17   Additional Bankruptcy Matters 40
7.            PRODUCT-RELATED CONTRACTS 40
8.            EVENTS OF DEFAULT 41
8.1   Payments 41
8.2   Covenants 41
8.3   Judgments 41
8.4   Voluntary Bankruptcy, etc. 42
8.5   Involuntary Bankruptcy, etc. 42
8.6   Default Under Other Agreements 42
8.7   Representations, etc. 42
8.8   Guaranty 42
8.9   Security Documents 42
8.10   Loan Documents 43
8.11   Change in Control 43
8.12   Section 364 Financing 43
8.13   Other Superpriority Claims and Liens 43
8.14   Dismissal or Conversion of Cases 43
8.15   Automatic Stay 43
8.16   Modification to DIP Orders, Etc. 44
8.17   Prepetition Payments 44
8.18   Compliance with Orders 44
8.19   Sale of Assets; Etc. 44
8.20   Reorganization Plan 44

 

 

-iv-